Fig. 1
From: Identification of FtfL as a novel target of berberine in intestinal bacteria
BBR inhibits the growth of pathogenic bacteria of CRC. A Chemical structure of BBR. B–F BBR inhibits the growth of pathogenic bacteria of CRC in a dose-dependent manner, including P. anaerobius ATCC 27337, F. nucleatum ATCC 10953, C. symbiosum ATCC 14940, S. faecalis ATCC 19433, and L. lactis DSM 20481. Data are presented as the mean ± S.D. of three independent replicates. The statistical significance of the differences in bacterial growth between the control strain and the other two strains (0.3 mM and 0.6 mM BBR) were assessed by the two-way ANOVA with Tukey’s multiple comparison test (***p < 0.001; **p < 0.01; *p < 0.05)